0000814453-25-000107
SEC filingNet sales declined 7.2% YoY in Q3 2025 due to soft global demand and retailer inventory reductions, while operating income improved on cost savings and absence of impairment charges.
For the three months ended September 30, 2025, Newell Brands reported net sales of $1,806 million, down 7.2% from $1,947 million in the prior year. The decline was driven by continued softness in global demand across all segments, particularly in Home and Commercial Solutions (H&CS), and reduced retailer inventory levels primarily in Learning and Development (L&D). Foreign currency provided a modest $11 million benefit. Gross profit fell 9.3% to $616 million, and gross margin contracted 80 basis points to 34.1%, reflecting $55 million in incremental tariffs, inflation, and $6 million in product recall costs, partially offset by productivity gains and pricing. Operating income improved dramatically to $119 million from a loss of $121 million, primarily due to the absence of $260 million in non-cash impairment charges taken in the prior year, along with $36 million lower incentive compensation and restructuring savings. Net income was $21 million versus a loss of $198 million, with diluted EPS of $0.05 compared to -$0.48.
Management continues to navigate a challenged macro environment and expects incremental tariff costs of approximately $115 million recognized in 2025 (with $55 million in Q3 alone) and $180 million in cash tariff costs. The company is executing a mitigation strategy including pricing, productivity, and manufacturing relocation. Key strategic priorities for 2025 include returning to profitable top-line growth through innovation and distribution expansion, expanding margins, deleveraging the balance sheet, and driving operational excellence via complexity reduction and SKU optimization. The Realignment Plan is expected to be substantially completed by year-end 2025, yielding further savings. No quantitative guidance for revenue or EPS was provided.
As of September 30, 2025, Newell Brands held $229M in cash and cash equivalents, with total debt of $4.78B, resulting in a net debt position of $4.55B. Shareholders' equity stood at $2.70B, a decline from $2.75B at year-end 2024. Inventory increased 4% to $1.46B, while accounts receivable rose 7% to $943M. The company maintains a $1.0B revolving credit facility with $707M of net availability after outstanding borrowings and letters of credit. In Q2 2025, Moody's and S&P downgraded the company's senior unsecured debt to B1 and B+, respectively, triggering a 50bp interest rate increase on certain notes, expected to add ~$5M in annual interest expense.
The notes disclose no material purchase commitments or long-term supply agreements. The company has a supplier finance program with $17M outstanding obligations at September 30, 2025. Environmental remediation reserves total $33M, primarily for CERCLA sites. A recall reserve of $6M was recorded for Oster French Door Countertop Ovens. The company is party to the Lower Passaic River matter, with liability considered immaterial under a proposed consent decree, but litigation remains.
Dividends continued at $0.07 per share quarterly, totaling $90M for the nine months, flat YoY. No share repurchases were disclosed. The company raised $1.25B of 8.5% senior notes due 2028 in May 2025, using proceeds to fully redeem its $1.23B 4.2% notes due 2026, resulting in a $13M loss on extinguishment. Capital expenditures totaled $177M for the nine months, with $59M in Q3, primarily in Corporate ($75M) and H&CS ($56M).
The three reportable segments showed divergent performance. H&CS saw sales decline 10% YoY to $942M but swung from a $94M operating loss to a $40M profit, driven by lower impairment charges ($0 vs $260M). L&D sales fell 5% to $681M, while operating income rose to $124M from $75M, benefiting from lower restructuring costs. O&R sales were flat at $183M, reducing its operating loss from $23M to $8M. Geographically, North America accounted for 67% of total sales, down from 68% YoY. International sales fell 5%, with particular weakness in H&CS international (-6%) and L&D international (-8%).